Nov 07, 2019

Philips highlights importance of digital health to address healthcare challenges at the Future Investment Initiative

Philips participated at the Future Investment Initiative where global leaders addressed utilizing investment to drive growth opportunities and address global challenges.

Royal Philips (NYSE: PHG; AEX: PHIA), a global leader in health technology, laid emphasis on the role of sustainable innovation in the Kingdom’s journey towards achieving healthcare transformation, at the Future Investment Initiative (FII) that took place in Riyadh from 29th-31st October 2019.

As part of Philips’ commitment to make the world healthier and more sustainable through innovation, the company aims to address pressing societal issues with a focus on the United Nation’s Sustainable Development Goals, including the goal to ensure healthy lives and promote well-being for all at all ages.

FII brought together decision makers, leading investors and global experts to explore future economic trends and discuss how investment in advanced technologies can help transform Saudi Arabia into an economic powerhouse. In line with this, Frans van Houten, CEO of Royal Philips was a panelist in a session titled “Solving the unsolvable: How investors and entrepreneurs can advance deep tech” on Wednesday, October 30th. The session was moderated by Charles-Edouard Bouée, Senior Advisor for Roland Berger, in Germany, and also hosted other industry leaders such as Patrice Caine, CEO of Thales Group in France, Dr. Hong Chen, Chairman & CEO of The Hina Group in China, Robert F. Smith, Founder, Chairman and CEO of Vista Equity Partners in the United States, Masayoshi Son, the Founder & CEO of Softbank, in Japan, Dr. Kai Yu, Founder and CEO of Horizon Robotics in the United States and Ian Zhu, Managing partner of NIO Capital in China. The session put the spotlight on private-public sector collaborations to drive investments in technologies such as artificial intelligence and blockchain, which can redefine markets and industries to amplify growth opportunities.

Our vision is to improve the lives of three billion people a year by 2030. We want to transform the ways in which healthcare is accessed and experienced. Focused on the largescale disruption offered by precision diagnosis, personalized treatments and fully integrated care pathways. In the hospital and in the home. Addressing so-called Quadruple Aim: improved outcomes, increased patient experience and staff satisfaction, and reduced costs per capita. Philips is a leader in Artificial Intelligence in healthcare: unlocking unprecedented improvements in access, productivity and quality. With a rapid rate of innovation, AI can address significant global unmet needs in healthcare - augmenting human intuition and teamwork with precision and speed, at scale

Ozlem Fidancı

CEO of Philips Middle East and Turkey

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2018 sales of EUR 18.1 billion and employs approximately 77,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

Click here to read more Click here to read less